2025 Partners
Vernalis
Expertise Partner
For more than 25 years Vernalis has been working with a wide range of organisations to enable drug discovery programs against some of the most challenging therapeutic targets. From protein-protein interactions to novel targets classes, we have developed a deep expertise in helping our partners identify novel, validated hits using a wide range of integrated techniques, and to take these hits forward into robust, reliable leads and candidates.
OpenBench
Expertise Partner
OpenBench is pioneering success-driven early discovery collaborations. We bear the cost and scientific risk of screening, so the first dollar our partners spend is to purchase potent, novel, and developable chemical IP. OpenBench's structure-based artificial intelligence powers the success-driven model, designing the most potent compounds that bind a diverse array of targets, including enzymes, receptors, transcription factors, and transport proteins. We discover agonists, competitive and allosteric inhibitors, and non-functional binders for use in proximity-inducing modalities.
Collaborative Drug Discovery (CDD)
Expertise Partner
Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface.